{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T10:48:02Z","timestamp":1791110882254,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100021065","name":"Foundation for Applied Research in Gastrointestinal Oncology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100021065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.ejso.2023.07.002","type":"journal-article","created":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T11:14:18Z","timestamp":1688814858000},"page":"106976","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["A narrative review of what can HIPEC do"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2431-7366","authenticated-orcid":false,"given":"Paul H.","family":"Sugarbaker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl 3","key":"10.1016\/j.ejso.2023.07.002_bib1","first-page":"60","article-title":"Prognostic factors of rectum carcinoma \u2013 experience of the German multicenter study SGCRC. German study group colorectal carcinoma","volume":"81","author":"Hermanek","year":"1995","journal-title":"Tumori"},{"key":"10.1016\/j.ejso.2023.07.002_bib2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/jso.2930480532","article-title":"Local recurrence after curative resection for colorectal cancer: frequency, risk factors and treatment","volume":"2","author":"Stipa","year":"1991","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2023.07.002_bib3","first-page":"5790","article-title":"Early postoperative intraperitoneal chemotherapy as an adjuvant therapy to surgery for peritoneal carcinomatosis from gastrointestinal cancer: pharmacologic studies","volume":"50","author":"Sugarbaker","year":"1990","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.ejso.2023.07.002_bib4","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00000658-199101000-00008","article-title":"A\u00a0clinical pilot study combining surgery with intraoperative pelvic hyperthermochemotherapy to prevent the local recurrence of rectal cancer","volume":"213","author":"Fujimoto","year":"1991","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2023.07.002_bib5","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1177\/014107688808100904","article-title":"The \u201choly plane\u201d of rectal surgery","volume":"81","author":"Heald","year":"1988","journal-title":"J\u00a0R Soc Med"},{"key":"10.1016\/j.ejso.2023.07.002_bib6","doi-asserted-by":"crossref","unstructured":"Quirke P, Durdey P, Dixon MF, Williams NS. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical incision. Lancet 19865;ii:996-999..","DOI":"10.1016\/S0140-6736(86)92612-7"},{"key":"10.1016\/j.ejso.2023.07.002_bib7","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1200\/JCO.2012.42.9597","article-title":"Randomized trial of short-course radiotherapy versus long course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: trans-Tasman Radiation Oncology Group Trial 01.04","volume":"30","author":"Ngan","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2023.07.002_bib8","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00280-005-0074-8","article-title":"Pharmacokinetic changes induced by the volume of chemotherapy solution in patients treated with hyperthermic intraperitoneal mitomycin C","volume":"57","author":"Sugarbaker","year":"2006","journal-title":"Cancer Chemother Pharmacol"},{"issue":"2","key":"10.1016\/j.ejso.2023.07.002_bib9","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/0002-9610(89)90527-8","article-title":"Implantation metastasis as a cause of local recurrence of colorectal carcinoma","volume":"157","author":"Long","year":"1989","journal-title":"Am J Surg"},{"key":"10.1016\/j.ejso.2023.07.002_bib10","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1002\/1097-0142(19941015)74:8<2224::AID-CNCR2820740804>3.0.CO;2-A","article-title":"A\u00a0phase I trial of immediate postoperative intraperitoneal floxuridine and leucovorin plus systemic 5-fluorouracil and levamisole after resection of high risk colon cancer","volume":"74","author":"Kelsen","year":"1994","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.ejso.2023.07.002_bib11","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1038\/bjc.1998.225","article-title":"Combined intravenous and intraperitoneal chemotherapy with fluorouracil\u00a0+ leucovorin vs. fluorouracil\u00a0+ levamisole for adjuvant therapy of resected colon carcinoma","volume":"77","author":"Scheithauer","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejso.2023.07.002_bib12","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.1200\/JCO.1999.17.11.3560","article-title":"Multicenter phase II study of bimonthly high-dose leucovorin, fluorouracil infusion, and oxaliplatin for metastatic colorectal cancer resistant to the same leucovorin and fluorouracil regimen","volume":"17","author":"Andre","year":"1999","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2023.07.002_bib13","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJM200009283431302","article-title":"Irinotecan plus fluorouracil and leucovorin for metastatic colon cancer. Irinotecan Study Group","volume":"343","author":"Saltz","year":"2000","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.ejso.2023.07.002_bib14","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/S1470-2045(16)30500-9","article-title":"Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database","volume":"17","author":"Franko","year":"2016","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2023.07.002_bib15","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S1470-2045(20)30599-4","article-title":"Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"Qu\u00e9net","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2023.07.002_bib16","series-title":"Cytoreductive surgery & perioperative chemotherapy for peritoneal surface malignancy. Textbook and video atlas","first-page":"47","article-title":"Cancer chemotherapy for peritoneal metastases. Pharmacology and treatment","author":"Van der Speeten","year":"2017"},{"key":"10.1016\/j.ejso.2023.07.002_bib17","first-page":"1501","article-title":"Heat penetration in locally applied hyperthermia in the abdomen during intra-operative hyperthermic intraperitoneal chemotherapy","volume":"23","author":"Van Ruth","year":"2003","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ejso.2023.07.002_bib18","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0277-5379(90)90137-I","article-title":"Experimental and clinical status of intraperitoneal chemotherapy","volume":"26","author":"Los","year":"1990","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejso.2023.07.002_bib19","first-page":"431","article-title":"Research on the best chemohyperthermia technique of treatment of peritoneal carcinomatosis after complete resection","volume":"1","author":"Elias","year":"2000","journal-title":"Int J Surg Invest"},{"issue":"4","key":"10.1016\/j.ejso.2023.07.002_bib20","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.ejso.2020.09.017","article-title":"Colorectal cancer cells from patients treated with FOLFOX or CAPOX are resistant to oxaliplatin","volume":"47","author":"Nagourney","year":"2021","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2023.07.002_bib21","series-title":"Peritoneal carcinomatosis: principles of management","first-page":"415","article-title":"A\u00a0simplified approach to hyperthermic intraoperative intraperitoneal chemotherapy (HIIC) using a self retaining retractor","author":"Sugarbaker","year":"1996"},{"key":"10.1016\/j.ejso.2023.07.002_bib22","first-page":"79","article-title":"New prospects for the control of peritoneal surface dissemination of gastric cancer using perioperative intraperitoneal chemotherapy","volume":"2","author":"Sethna","year":"2004","journal-title":"Cancer Ther"},{"issue":"3","key":"10.1016\/j.ejso.2023.07.002_bib23","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/jso.26520","article-title":"Peritoneal cytology as an indicator of peritoneal metastases in colorectal cancer","volume":"124","author":"Sugarbaker","year":"2021","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2023.07.002_bib24","first-page":"1840","article-title":"Treatment of implanted peritoneal cancer in rats by continuous hyperthermic peritoneal perfusion in combination with an anticancer drug","volume":"44","author":"Koga","year":"1984","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejso.2023.07.002_bib25","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/1097-0142(19880115)61:2<232::AID-CNCR2820610205>3.0.CO;2-U","article-title":"Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin C","volume":"61","author":"Koga","year":"1988","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.ejso.2023.07.002_bib26","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1245\/s10434-007-9487-4","article-title":"A\u00a0systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer","volume":"14","author":"Yan","year":"2007","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2023.07.002_bib27","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00000658-199809000-00007","article-title":"Prospective randomized trial of early postoperative intraperitoneal chemotherapy as an adjuvant to resectable gastric cancer","volume":"223","author":"Yu","year":"1998","journal-title":"Ann Surg"},{"issue":"suppl","key":"10.1016\/j.ejso.2023.07.002_bib28","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.21037\/jgo-20-129","article-title":"Hyperthermic intraperitoneal chemotherapy in prevention of gastric cancer metachronous peritoneal metastases: a systematic review","volume":"12","author":"Reutovich","year":"2021","journal-title":"J\u00a0Gastrointest Oncol"},{"key":"10.1016\/j.ejso.2023.07.002_bib29","first-page":"414","article-title":"Prospective randomized trial of intravenous versus intraperitoneal 5 fluorouracil in patients with advanced primary colon or rectal cancer","volume":"98","author":"Sugarbaker","year":"1985","journal-title":"Surgery"},{"key":"10.1016\/j.ejso.2023.07.002_bib30","series-title":"Patterns of recurrence in women with ovarian cancer having hysterectomy for treatment of primary disease","author":"Sugarbaker","year":"2021"},{"issue":"3","key":"10.1016\/j.ejso.2023.07.002_bib31","doi-asserted-by":"crossref","first-page":"e193","DOI":"10.1097\/AS9.0000000000000193","article-title":"Extent of disease on visceral peritoneal surfaces of mucinous appendiceal neoplasms controls survival","volume":"3","author":"Sugarbaker","year":"2022","journal-title":"Annals of Surgery Open"},{"issue":"Supplement 7","key":"10.1016\/j.ejso.2023.07.002_bib32","first-page":"S680","article-title":"314O Adjuvant hyperthermic intraperitoneal chemotherapy in locally advanced colon cancer (HIPECT4): a randomized phase III study","volume":"33","author":"Arjona-Sanchez","year":"2022","journal-title":"Abstract Only"},{"issue":"1","key":"10.1016\/j.ejso.2023.07.002_bib33","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1470-2045(05)70539-8","article-title":"New standard of care for appendiceal epithelial malignancies and pseudomyxoma peritonei syndrome","volume":"7","author":"Sugarbaker","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2023.07.002_bib34","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ijscr.2020.09.017","article-title":"Perioperative FOLFOX in management of peritoneal metastases of colorectal cancer. Case report of 2 patients","volume":"75","author":"Sugarbaker","year":"2020","journal-title":"Int J Surg Case Rep"},{"key":"10.1016\/j.ejso.2023.07.002_bib35","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1245\/s10434-020-09388-4","article-title":"Intraperitoneal administration of paclitaxel combined with S-1 plus oxaliplatin as induction therapy for patients with advanced gastric cancer with peritoneal metastases","volume":"28","author":"Saito","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2023.07.002_bib36","first-page":"1587","article-title":"Efficacy of postoperative intraperitoneal hyperthermic perfusion chemotherapy with oxaliplatin\u00a0+ 5-fluorouracil in the treatment of gastric cancer patients with peritoneal carcinomatosis","volume":"24","author":"Yan","year":"2019","journal-title":"JBUON"},{"issue":"8","key":"10.1016\/j.ejso.2023.07.002_bib37","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.13940","article-title":"Evaluation of cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for stage III epithelial ovarian cancer","volume":"3","author":"Lei","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ejso.2023.07.002_bib38","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1016\/j.ejso.2021.05.014","article-title":"Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy vs. cytoreductive surgery alone for intrahepatic cholangiocarcinoma with peritoneal metastases: a retrospective cohort study","volume":"47","author":"Feng","year":"2021","journal-title":"Eur J Surg Oncol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798323005693?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798323005693?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T05:38:04Z","timestamp":1782884284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798323005693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0748798323005693"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2023.07.002","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A narrative review of what can HIPEC do","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2023.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106976"}}